drugset / Trial / NCT07497074
JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer
Non-randomizedSequentialOpen-labelTreatment
Summary
The goal of this clinical trial is to learn if the therapy of JSKN033 plus chemotherapy with or with bevacizumab is safe to treat patients with advanced cervical cancer. It will also learn about the antitumor activity and pharmacokinetic/ pharmacodynamic profiles of this therapy.
Timeline
- Start
- 2026-04
- Primary completion
- 2027-10
- Completion
- 2028-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | — | Intravenous |
| Subject | JSKN033 | Unknown | — | Intravenous |
| Background | Carboplatin | Small molecule | — | Intravenous |
| Background | Cisplatin | Other / unclassified | — | Intravenous |